Title |
Angiogenesis inhibitors for the treatment of ovarian cancer
|
---|---|
Published in |
Cochrane database of systematic reviews, September 2011
|
DOI | 10.1002/14651858.cd007930.pub2 |
Pubmed ID | |
Authors |
Kezia Gaitskell, Igor Martinek, Andrew Bryant, Sean Kehoe, Shibani Nicum, Jo Morrison |
Abstract |
Many women with ovarian cancer eventually develop resistance to conventional chemotherapy drugs, and so novel agents are being developed to target specific molecular pathways. One such class of drugs inhibits angiogenesis (the development of new blood vessels), which is essential for tumour growth. It is important to establish whether the addition of these new drugs to conventional chemotherapy regimens improves survival, and what the side-effects may be. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Ecuador | 2 | 1% |
Spain | 1 | <1% |
Italy | 1 | <1% |
Unknown | 182 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 24 | 13% |
Researcher | 22 | 12% |
Student > Bachelor | 20 | 11% |
Student > Ph. D. Student | 18 | 10% |
Student > Doctoral Student | 11 | 6% |
Other | 30 | 16% |
Unknown | 61 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 79 | 42% |
Nursing and Health Professions | 11 | 6% |
Agricultural and Biological Sciences | 10 | 5% |
Biochemistry, Genetics and Molecular Biology | 7 | 4% |
Computer Science | 4 | 2% |
Other | 14 | 8% |
Unknown | 61 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2011.
All research outputs
#20,043,000
of 25,498,750 outputs
Outputs from Cochrane database of systematic reviews
#12,099
of 13,141 outputs
Outputs of similar age
#111,866
of 136,583 outputs
Outputs of similar age from Cochrane database of systematic reviews
#103
of 110 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,141 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 136,583 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.